![]()
MIRA INFORM REPORT
|
Report Date : |
24.02.2011 |
IDENTIFICATION DETAILS
|
Name : |
F.H.C.-FARMACEUTICA LDA |
|
|
|
|
Registered Office : |
Parque Industrial Manuel Lourenço Ferreira, Lote 2 - Apartado 45, Mortagua |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2009 |
|
|
|
|
Date of Incorporation : |
09.02.1998 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Wholesale trade of pharmaceutical products |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2010
|
Country Name |
Previous Rating (01.04.2010) |
Current Rating (30.06.2010) |
|
|
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Name |
F.H.C.-FARMACEUTICA LDA |
|
|
|
|
|
V.A.T. Number / NIF |
504061500 |
|
Address |
Parque Industrial Manuel Lourenço Ferreira, Lote 2 - Apartado 45 |
|
|
|
Locality |
MORTAGUA |
Postal Code |
3450-232-MORTAGUA |
|
Municipality |
MORTAGUA |
District |
VISEU |
|
Telephone |
231927510, 231927524 |
|
|
|
Fax |
231927520 |
|
|
|
E-Mail |
|
|
|
|
Web Site |
|
|
|
|
|
|
|
|
|
C.A.E.(Rev 3) |
46460- Wholesale trade of
pharmaceutical products |
|
|
|
All the amounts are express in Euros, otherwise you
will be advised |
|
Legal Form |
Private Limited Company |
|
|
|
Constitution |
09-02-1998 |
V.A.T. Number / NIF |
504061500 |
|
Employees |
200 |
Capital |
250.000,00 |
|
Sales in : 31-12-2009 |
50.245.514,00 |
Shareholders Funds in:
31-12-2009 |
16.046.770,00 |
|
Credit |
Recommended |
Credit Limit |
62.350,00 |
|
Condition |
|
Tendency |
Stationary |
|
Financing |
Guaranteed |
Payments |
Good |
|
Actual Condition |
In activity |
|
|
|
JOAQUIM ANTONIO DE MATOS CHAVES |
Managing-Partner |
|
BANCO ESPIRITO SANTO, SA |
Tondela |
|
MILLENNIUM BCP |
Mortágua |
|
Registed on the Register
Record Office of Mortagua with the Register Number 504061500 previous number 192
in 09-02-1998 |
|
Constitution celebrated
in 09-02-1998 published on Diário da República number 59 of 11-03-1998 |
|
To oblige the company it
is necessary 2 signature |
In 11-07-2003 on Diário da República
number 234 of 09-10-2003 increase of capital to 250.000 €
In 09-02-1999 on Diário da
República number 86 of 13-04-1999 board of director's change
|
The Capital is 250.000,00 |
|
|
with the following
distribution |
|
JOAQUIM ANTONIO DE MATOS CHAVES |
125.000,00 |
50% |
|
LUIS PEDRO GONCALVES SIMOES |
125.000,00 |
50% |
|
Name |
JOAQUIM ANTONIO DE MATOS CHAVES |
|
Function |
Managing-Partner |
|
Address |
Rua Dr. Teófilo da Cruz - Edifício Magistral, 3ºC |
|
Locality |
TONDELA |
|
Civil State |
Married |
|
Consort |
Isabel Cristina Jesus
Neves Ferreira |
|
Professional Connections |
The subject has
connections with the following company (ies) |
|
|
NOVAMED-EQUIPAMENTOS
MEDICOS SA as Board of Director's President . |
|
|
OVERPHARMA-PRODUTOS
MEDICOS E FARMACEUTICOS LDA as Managing-Partner with a participation of
79.166,77 , in a capital of 250.000,00 . |
|
|
CRISTRAVEL-VIAGENS E TURISMO LDA as Manager . |
|
|
PHAGECON-SERVICOS E
CONSULTORIA FARMACEUTICA LDA as Managing-Partner with a participation of
16.000,00 , in a capital of 60.000,00 . |
|
|
ALEXANDRA PINTO PACHECO UNIPESSOAL LDA as Manager . |
|
|
HEALTHICS-SGPS SA as Administrator . |
|
|
EMPIFARMA-PRODUTOS FARMACEUTICOS SA as Administrator . |
|
|
VITALGEST-CLINICAS
DENTARIAS LDA as Managing-Partner with a participation of 37.500,00 , in a
capital of 75.000,00 . |
|
|
ACTRADIA-FARMACEUTICA LDA
as Managing-Partner with a participation of 2.500,00 , in a capital of
5.000,00 . |
|
|
ZEONE-INFORMATICA LDA as
Managing-Partner with a participation of 3.334,00 , in a capital of 10.002,00
. |
|
|
LABORATORIOS
BASI-INDUSTRIA FARMACEUTICA SA as Board of Director's President . |
|
|
|
|
Name |
|
|
Function |
Partner |
|
Address |
Urbanização Quinta de S. Jerónimo-Lote 21-D, 1ºDto. |
|
Locality |
|
|
Birth Date |
29-03-1972 |
|
Naturality |
|
|
Civil State |
Divorced |
|
Academical Degree |
Licênciado em engenharia electrotécnica |
|
Professional Connections |
The subject has
connections with the following company (ies) |
|
|
VITALGEST-CLINICAS
DENTARIAS LDA as Managing-Partner with a participation of 37.500,00 , in a
capital of 75.000,00 . |
|
|
NOVAMED-EQUIPAMENTOS MEDICOS SA as Administrator . |
|
|
ALEXANDRA PINTO PACHECO UNIPESSOAL LDA as Manager . |
|
|
HEALTHICS-SGPS SA as Administrator . |
|
|
EMPIFARMA-PRODUTOS FARMACEUTICOS SA as Administrator . |
|
|
OVERPHARMA-PRODUTOS MEDICOS |
|
|
ACTRADIA-FARMACEUTICA LDA
as Managing-Partner with a participation of 2.500,00 , in a capital of
5.000,00 . |
|
|
ZEONE-INFORMATICA LDA as
Managing-Partner with a participation of 3.334,00 , in a capital of 10.002,00
. |
|
|
PHAGECON-SERVICOS E
CONSULTORIA FARMACEUTICA LDA as Managing-Partner with a participation of
16.000,00 , in a capital of 60.000,00 . |
|
|
LABORATORIOS BASI-INDUSTRIA FARMACEUTICA SA as Administrator . |
|
Observations |
It also has an address
in: Rua Miguel Torga, 249 – 5. º A, |
|
Event |
General Description |
|
Quality Certification |
The bearer is certified
by the standard ISO 9001/2000. |
|
Line of Business |
Percentage |
|
Import, export, marketing and distribution of pharmaceuticals, medical
devices, furniture and hospital
equipment and diagnostic material |
100% |
|
Type of Clients |
Hospitals/Pharmacies |
|
|
|
Sales Conditions |
Cash/credit |
|
|
|
Exports to |
ANGOLA, FRANCE, CAPE VERDE, GUINEA-BISSAU,
MOZAMBIQUE, SAO TOME AND PRINCIPE,
IVORY COAST, SPAIN, AZERBAIJAN, LEBANON, MACEDONIA,
NETHERLANDS |
|
|
|
Total |
200 |
|
Head office and warehouse Parque Indústrial Manuel Lourenço Ferreira,
Lt 2 - Apartado 45, MORTAGUA, 3450-232, MORTAGUA, Tel:231927510,
Fax:231927520 |
|
There are no of incidents
on our database |
|
Consulted sources say
that the subject has been respecting its payments and commercial commitments,
so credit connections with this company are recommended. |
The subject participates on the following company(ies)
|
NAME |
LABORATORIOS BASI-INDUSTRIA FARMACEUTICA SA |
|
Address |
Rua Padrão, 98 |
|
Locality |
|
|
Telephone |
239827021 |
|
Fax |
239492845 |
|
E-Mail |
basi@basi.pt |
|
Web Site |
|
|
C.A.E. |
21201- Manufacture of
medicines |
|
Capital |
1.326.935,00 |
|
Participation |
98% |
|
|
31-12-2009 |
|
|
Intangible Assets |
541.693,00 |
|
|
Tangible Assets |
1.373.003,00 |
|
|
Investments |
5.112.571,00 |
|
|
Stocks |
9.592.537,00 |
|
|
Short Term Receivable |
15.078.855,00 |
|
|
Banks and Cash |
3.145.566,00 |
|
|
Accruals and Deferrals |
51.377,00 |
|
|
Total Assets |
34.895.602,00 |
|
|
Shareholder's Funds |
16.046.770,00 |
|
|
Medium and Long Term
Payable |
2.847.125,00 |
|
|
Short Term Payable |
15.904.271,00 |
|
|
Accruals and Deferrals |
97.436,00 |
|
|
Total Liabilities and
Shareholder's Funds |
34.895.602,00 |
|
|
Cost of Goods and
Consumable Materials |
40.423.145,00 |
|
|
Outside Supplies and
Services |
4.847.512,00 |
|
|
Personnel Costs |
1.258.608,00 |
|
|
Sales |
50.245.514,00 |
|
|
Supplementary Income |
8.903,00 |
|
|
|
31-12-2007 |
31-12-2008 |
31-12-2009 |
|
Net Sales |
34.012.945,00 |
42.337.147,00 |
50.245.514,00 |
|
Net Income For the Year |
2.446.273,00 |
2.943.163,00 |
3.677.264,00 |
|
Current Assets |
28.292.296,00 |
21.401.435,00 |
27.868.335,00 |
|
Short Term Payables |
22.780.777,00 |
14.483.450,00 |
15.904.271,00 |
|
Cash Flow |
5.511.519,00 |
6.917.985,00 |
11.964.064,00 |
|
Total Assets |
33.053.505,00 |
27.477.136,00 |
34.895.602,00 |
|
Total Liabilities |
23.757.707,00 |
15.223.605,00 |
18.848.832,00 |
|
Shareholders Funds |
9.295.798,00 |
12.253.532,00 |
16.046.770,00 |
|
Personnel Costs |
1.016.971,00 |
678.033,00 |
1.258.608,00 |
|
|
31-12-2007 |
31-12-2008 |
31-12-2009 |
|
FINANCIAL SITUATION |
|
|
|
|
General Liquidity |
1,24 |
1,48 |
1,75 |
|
Immediate Liquidity |
0,92 |
0,92 |
1,15 |
|
Financial Autonomy |
0,28 |
0,45 |
0,46 |
|
Solvency |
0,39 |
0,80 |
0,85 |
|
RENTABILITY |
|
|
|
|
Sales Rentability |
7,19 % |
6,95 % |
7,32 % |
|
Sales Rate Increase |
|
24,47 % |
18,68 % |
|
EFFICIÊNCY |
|
|
|
|
Assets Turnover |
1,03 |
1,54 |
1,44 |
Balance Sheet
CoinEURO Date31-12-2009
|
|
Gross Assets |
Depreciations /
Provisions |
Net Assets |
|
Intangible Assets |
|
Subtotal |
1.205.729,00 |
664.036,00 |
541.693,00 |
|
Tangible Assets |
|
Subtotal |
2.633.579,00 |
1.260.576,00 |
1.373.003,00 |
|
Financial
Investments |
|
Subtotal |
5.112.571,00 |
|
5.112.571,00 |
|
Stocks |
|
Subtotal |
9.592.537,00 |
|
9.592.537,00 |
|
Short
Term Receivable |
|
Subtotal |
15.220.766,00 |
141.911,00 |
15.078.855,00 |
|
Bank
Deposits and Cash |
|
Cash |
9.584,00 |
|
9.584,00 |
|
Bank Deposites |
3.135.982,00 |
|
3.135.982,00 |
|
Subtotal |
3.145.566,00 |
|
3.145.566,00 |
|
Accruals
and Deferrals |
|
Deferred Cost |
51.377,00 |
|
51.377,00 |
|
Subtotal |
51.377,00 |
|
51.377,00 |
|
Total Assets |
36.962.125,00 |
2.066.523,00 |
34.895.602,00 |
|
Shareholders
Funds and Liabilities |
|
Shareholders Funds |
|
Capital |
250.000,00 |
|
|
Treasury Stock: |
|
|
|
Other Sup. |
190.000,00 |
|
|
Reserves : |
|
|
|
Free |
561.710,00 |
|
|
Net Retained |
11.367.797,00 |
|
|
Net Income For the Year |
3.677.264,00 |
|
|
Total |
16.046.770,00 |
|
|
Short
Term Payable |
|
Bank Loans |
5.500.000,00 |
|
|
Supliers Fixed Asset |
20.370,00 |
|
|
State and Other Public
Bodies |
239.371,00 |
|
|
Other Creditors |
412.327,00 |
|
|
Trade Creditors |
9.732.203,00 |
|
|
Subtotal |
15.904.271,00 |
|
|
Medium
and Long Term Payable |
|
Bank Loans |
2.591.654,00 |
|
|
Adv. For Clients |
157.006,00 |
|
|
State and Other Public
Bodies |
98.465,00 |
|
|
Subtotal |
2.847.125,00 |
|
|
Accruals
and Deferrals |
|
Accrued Charges |
90.096,00 |
|
|
Diferred Income |
7.340,00 |
|
|
Subtotal |
97.436,00 |
|
|
TOTAL LIABILITIES |
18.848.832,00 |
|
|
TOTAL LIABILITIES AND
SHAREHOLDERS FUNDS |
34.895.602,00 |
|
|
Income
Statement |
|
Costs
and Losses |
|
Cost of Materials
Consumed and Goods Sold: |
|
|
|
Subtotal |
40.423.145,00 |
|
|
Outside Supplies and
Services |
4.847.512,00 |
|
|
Personnel Costs |
|
|
|
Subtotal |
1.258.608,00 |
|
|
Depreciation |
425.318,00 |
|
|
Provisions |
52.538,00 |
|
|
Subtotal |
477.856,00 |
|
|
Other Operating Costs |
96.732,00 |
|
|
Int. and Similar Costs: |
|
|
|
Subtotal |
1.042.301,00 |
|
|
Ext. Costs and Losses |
482.259,00 |
|
|
Taxation Over Income |
845.272,00 |
|
|
Net Income For the Year |
3.677.264,00 |
|
|
Income
and Profits |
|
Sales of : |
|
|
|
Products |
49.972.556,00 |
|
|
Services Provided |
272.958,00 |
|
|
Subtotal |
50.245.514,00 |
|
|
Supplementary Income |
8.903,00 |
|
|
Other Operating Income
and Gains |
1.399.029,00 |
|
|
Subtotal |
1.407.932,00 |
|
|
Trading Securities Income
|
|
|
|
Int. and Similar Costs |
|
|
|
Other |
1.386.326,00 |
|
|
Extra Income and Gains |
111.176,00 |
|
|
Net Income For the Year |
3.677.264,00 |
|
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.20 |
|
|
1 |
Rs.73.17 |
|
Euro |
1 |
Rs.61.88 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.